Home
About Us
Avalo Therapeutics is a clinical stage biotechnology company focused on the treatment of immune mediated inflammatory diseases.
Presentations
Recent News
Apr 30, 2025 7:00 am
Avalo Therapeutics to Participate in The Citizens Life Sciences Conference
Mar 26, 2025 7:00 am
Avalo Therapeutics Appoints Michael Heffernan as Chairman of the Board
